Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026)

Cerus' (CERS) quarterly Liabilities and Shareholders Equity came in at $222.9 million in Q1 2026, up 7.8% year-on-year from $206.8 million in Q1 2025, and little changed quarter-over-quarter from $221.9 million in Q4 2025.

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Cerus has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $222.9 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $222.9 million, up 7.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $873.0 million (up 11.54% YoY), and the FY2025 annual result was $221.9 million, up 10.42% from the prior year.
  • Liabilities and Shareholders Equity came in at $222.9 million for Q1 2026 at Cerus, roughly flat from $221.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $222.9 million in Q1 2026 to a low of $185.5 million in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $209.3 million (2023), against an average of $207.6 million.
  • Across the five-year window, Liabilities and Shareholders Equity decreased 9.65% in 2024 and advanced 14.87% in 2025, its largest moves.
  • Cerus' Liabilities and Shareholders Equity stood at $218.1 million in 2022, then retreated by 9.33% to $197.7 million in 2023, then advanced by 1.6% to $200.9 million in 2024, then rose by 10.42% to $221.9 million in 2025, then climbed by 0.47% to $222.9 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $222.9 million (Q1 2026), $221.9 million (Q4 2025), and $215.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 110.43 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 46.29 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 37.13 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 6.63 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 10.74 Bn
10 Cerus 496.03 Mn 416.34 Mn 27.89 Mn 222.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 222.91 Mn
Dec 31, 2025 221.86 Mn
Sep 30, 2025 215.19 Mn
Jun 30, 2025 213.07 Mn
Mar 31, 2025 206.78 Mn
Dec 31, 2024 200.92 Mn
Sep 30, 2024 189.54 Mn
Jun 30, 2024 185.50 Mn
Mar 31, 2024 189.14 Mn
Dec 31, 2023 197.75 Mn
Sep 30, 2023 205.84 Mn
Jun 30, 2023 198.86 Mn
Mar 31, 2023 209.34 Mn
Dec 31, 2022 218.09 Mn
Sep 30, 2022 215.40 Mn
Jun 30, 2022 216.46 Mn
Mar 31, 2022 221.91 Mn
Dec 31, 2021 237.50 Mn
Sep 30, 2021 218.95 Mn
Jun 30, 2021 223.22 Mn